Development of DNA Topoisomerase II-Mediated Anticancer Agents, 3-(9- Acridinylamino)-5-hydroxymethylanilines (AHMAs) and Related Compounds

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|9|18|1677-1688

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.9, Iss.18, 2002-09, pp. : 1677-1688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase II As Novel Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 694-709

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments of DNA Poisons - Human DNA Topoisomerase II Inhibitors - as Anticancer Agents

By  

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2474-2488

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 15, 2016-09 ,pp. : 1219-1229

Bentham Science Publishers

Access to resources Recommend Favorite

Non-camptothecin topoisomerase I active compounds as potential anticancer agents

By Long B.H.   Balasubramanian B.N.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 635-666

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs

By  

Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. : 4270-4290

Bentham Science Publishers

Access to resources Recommend Favorite